alzheimer-disease

Documents about alzheimer-disease

• Feature fusion and WOA-GWO optimization for Alzheimer’s disease detection with sparse EEG channels.#221212NCBI PubMed Central
• Escherichia coli Nissle 1917 alleviates Alzheimer's disease in mice through OmpA-containing outer membrane vesicles.#222836NCBI PubMed Central
• APOE ε4 carriership status enhances age-related changes in Alzheimer’s disease plasma biomarkers concentrations#231420Europe PMC
• Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer’s Disease.#244352NCBI PubMed Central
• Identification of functional non-coding variants affecting Alzheimer's disease risk by Massively Parallel Reporter Assay#252828bioRxiv / medRxiv
• A data-driven Alzheimer's disease progression simulator for retrospective validation and prospective Phase III power design#252875bioRxiv / medRxiv
• Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.#260287NCBI PubMed Central
• Is there a cognitive measure of neurodegeneration for amyloid-Aβ-ratio probable Alzheimer's disease patients?#262904NCBI PubMed Central
• Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.#263033NCBI PubMed Central
• Improved Multiscale Structural Mapping with Supervertex Vision Transformer for the Detection of Alzheimer's Disease Neurodegeneration.#265271NCBI PubMed Central
• Neuropathological study of the effects of aducanumab anti-Aβ immunotherapy on patients with Alzheimer's disease.#288590NCBI PubMed Central
• Deep Learning and Machine Learning for Early Detection of Alzheimer's Disease: A Systematic Review and Meta-Analysis#296520bioRxiv / medRxiv
• Gender differences in informal caregiving costs and burden in Alzheimer disease: a multinational cross-sectional analysis.#305254NCBI PubMed Central
• Design of an artificial intelligence model to screen spontaneous speech to detect Alzheimer's Disease#314742Europe PMC
• Calibrating microglia states in Alzheimer's disease: decoding immune-metabolic networks and nano-targeted multicomponent therapies.#330671NCBI PubMed Central
• Combining β 2 -AR agonism with butyrylcholinesterase inhibition, a synergistic neuroprotective action against Alzheimer's disease#350562HAL (France)
• Alzheimer's disease neuroimaging signature aids identification of cognitive impairment in older adults with early-onset epilepsy#353175bioRxiv / medRxiv
• What Are the Potential Therapeutic Benefits of Targeting Blood-Borne Lipoproteins in the Treatment of Alzheimer's Disease?#367987NCBI PubMed Central
• Spatiotemporal dynamics of tau extent and load increase in Alzheimer's disease across four longitudinal cohorts.#380719NCBI PubMed Central
• Multiple sclerosis as a genetic risk factor for Alzheimer's disease: Insights from Mendelian randomisation.#385145NCBI PubMed Central
• Slow-wave sleep across the Alzheimer's disease continuum: cognitive trajectories and sex differences#387644Europe PMC
• Association between Alzheimer's disease and MHC-I antigen processing and presentation pathway: a narrative review.#402457NCBI PubMed Central
• Criterion-Referenced Sex-Specific Six-Minute Walk Distance Cut-Offs for Staging Alzheimer's Disease.#409129NCBI PubMed Central
• Omega-3 Fatty Acids and Alzheimer's Disease: Toward a New Understanding of Neuroprotective Mechanisms and Intervention Strategies.#409204NCBI PubMed Central
• Associations of antibodies against several infections with Alzheimer disease neuropathology: a prospective cohort study analysis#424616Europe PMC
• Classifying Alzheimer's Disease Using Audio and Text-Based Representations of Speech#427506MIT Open Scholarship
• Associations of Alzheimer Disease and Related Dementia Neuropathologies With Timely Diagnosis of Dementia in Healthcare Settings.#437130NCBI PubMed Central
• A randomized phase 1b/2 trial of ABBV-916 in adults with early Alzheimer's disease.#438942NCBI PubMed Central
• LSEAD: A Privacy-Preserving LLM-Based Speech Analysis Framework for Early Alzheimer's Disease Screening#440363arXiv CS
• Regional astrocyte dysregulation and altered glymphatic-related markers in Alzheimer's disease frontal cortex.#457459NCBI PubMed Central
• In Silico Evaluation Of The Iron Chelator Deferoxamine As A Potential Acetylcholinesterase (AcHe) Inhibitor For Alzheimer's Disease#467436AVESIS
• Divergent trends in Alzheimer's disease burden: a comparative analysis of the US and G20 nations.#472667NCBI PubMed Central
• A Biologically Constrained Continuous-Time Framework for Long-Horizon Cognition Forecasting in Alzheimer’s Disease#475666Europe PMC
• An information-theoretic evaluation framework for CNN-LSTM-based Alzheimer's disease classification from structural MRI.#479300NCBI PubMed Central
• Novel cell markers with altered expression in brain aging and Alzheimer's disease: A review.#480823NCBI PubMed Central
• Comparator supplement patterns qualify the clinical interpretation of an EHR-derived glucosamine signal in Alzheimer's disease#481630bioRxiv / medRxiv
• Racial and ethnic differences in older adults’ willingness to be contacted about Alzheimer's disease research participation#491812eScholarship
• Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease#609426eScholarship
• Effects of physical exercise on cognitive impairment in patients with Alzheimer's disease, Parkinson's disease or mild cognitive impairment: a systematic review and meta-analysis.#288888NCBI PubMed Central
• Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer's disease continuum.#607NCBI PubMed Central
• Brain network dynamics determine tau presence while regional vulnerability governs tau load in Alzheimer’s disease#4852Europe PMC
• Diagnostic performance of salivary markers of Alzheimer's disease: A systematic review#5490Europe PMC
• Targeting of Itch by clomipramine or gene therapy improves cognitive defects related to Alzheimer's disease#5586Europe PMC
• APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's Disease.#9004NCBI PubMed Central
• Evaluating the peripheral nervous system pathology of Alzheimer's disease utilizing a functional human NMJ microphysiological system.#28211NCBI PubMed Central
• Elevated plasma klotho levels attenuate Alzheimer's disease pathologies and cognitive decline in APOE ε4 carriers.#30862NCBI PubMed Central
• Deconstructing bilingualism and its sociocultural determinants in cognitive aging and Alzheimer's disease and related dementias.#125255NCBI PubMed Central
• Repeated low-intensity focused ultrasound induces microglial profile changes in the TgF344-AD rat model of Alzheimer disease#133191bioRxiv / medRxiv
• Feasibility of identifying factors related to Alzheimer's disease and related dementia in real-world data.#138572NCBI PubMed Central
• SPECT and PET imaging of Alzheimer's disease revisited: from biomarkers to artificial intelligence-based prediction.#145997NCBI PubMed Central